Real World Data on Management of Male LUTS

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

201 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-05-19

Study Completion Date

2016-12-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will describe the current medical care given to men who discuss their lower urinary tract symptoms with a HCP. It will document the primary reasons for the visit, the baseline characteristics of these men, the treatment received, and the practice patterns of specifically a primary care physician managing these patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Identification and Treatment of Men With BPH in the Primary Care Setting

NCT00211640

No Conditions for This Study. All Male Patients 18 Years of Age or Older Were Administered the LUTS, MSHQ, and Patient Demographics Questionnaire

COMPLETED

Interest of a Systematic Assessment of the Treatment of LUTS in the Management of BPH

NCT03179670

Benign Prostatic Hyperplasia

COMPLETED

RELIEF Study: Real-world Evaluation of LUTS Interventions and Patient Experience During Follow-up

NCT05784558

Benign Prostatic Hyperplasia

NOT_YET_RECRUITING

Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

NCT01939184

Benign Prostatic Hyperplasia

COMPLETED PHASE2

Study of Median Lobe Prostatic UroLift Procedure

NCT02625545

Benign Prostatic Hyperplasia (BPH)

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Benign Prostatic Hyperplasia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Males, aged ≥18 years old.
* Having had discussion of urinary symptoms with their PCP between 15 days and 12 months prior to the date of the phone interview.
* Able to read, speak and understand English.
* Willing to provide informed consent for study participation, authorize the release of their previous 12-month medical records from their PCP for review and de-identified data entry by Mapi into an electronic study database.

Exclusion Criteria

* Reported during screening that they had had their first-ever discussion of urinary symptoms with PCP within the 14 days prior to the date of the phone interview.
* Participation in a clinical research study that evaluated urinary symptoms in the past 12 months.
* Self-reported history of colorectal, bladder or prostate cancer.
* Self-reported neurologic disorders that affect bladder function, e.g., neurogenic bladder disorders due to spinal cord injury/disease, multiple sclerosis, Parkinsons disease.
* Self-reported history of radiation therapy to the lower abdominal and/or pelvic region.

Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No